Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 1997

View Archived Issues

Gruenenthal prepares analgesics

Analgesic/antiinflammatory agent from Merck KGaA

Dual-action compounds for BPH described by Zeria

Antifungal agent revealed by Bayer

ADIR prepares antiangiogenic agents

German researchers focus on Na+/H+-exchange inhibitors

Antitumor agents from Taiho

Novel omega-conotoxin peptides described

Dual leukotriene/thromboxane antagonists described by Hokuriku

Natural 5alpha-reductase inhibitors discovered at Taisho

Meiji Milk discloses new gold complex

Patent coverage granted for LXR antidiarrheal agent

Novavax retains investment bank for licensing

Medis El teams with Ramot to develop breast cancer vaccines

Catalytica to acquire Glaxo Wellcome pharmaceutical facility

TCPI and Taiho agreement for diagnostic test

Vyrex gene discovery platform receives patent coverage

Rotavirus diagnostic approved in Germany

Milestone achieved in Microcide/Pfizer collaboration

Pall establishes European manufacturing site

Grant helps fund research into camptothecin analogues

Structure of protease involved in osteoporosis solved

Introgen receives milestone payment for gene therapy progress

Launch date for Aricept revealed

Genentech funds basic research related to human birth defects

BioSpecifics Technologies is issued 9th U.S. patent for use of collagenase enzyme

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...